Antiaging Quantum Living Inc

Previous wording

During the three months ended September 30, 2024 and 2023, the Company generated revenue in the amount of $173,174 and $nil, respectively. During the three months ended September 30, 2024 and 2023, the Company incurred operating expenses of $356,569 and $24,378, respectively. The increase in revenues and costs are related to the sales of health and beauty products which commenced since October 1, 2023. The Company also generated revenues in the amounts of $110,946 for its online platform technical operation support and maintenance services during the three months ended September 30, 2024.

Current wording

During the three months ended December 31, 2024 and 2023, the Company generated revenue in the amount of $154,471 and $6,299, respectively. During the three months ended December 31, 2024 and 2023, the Company incurred operating expenses of $348,125 and $102,632, respectively. The increase in revenues and costs are related to revenues generated from its online platform technical operation support and maintenance services during the three months ended December 31, 2024.

Previous wording

For the three months ended September 30, 2024, our net loss was $197,746 comparing to a net loss of $24,378 for the three months ended September 30, 2023. The increase in net loss is mainly due to the increased operating expenses.

Current wording

For the three months ended December 31, 2024, our net loss was $129,154 comparing to a net loss of $97,090 for the three months ended December 31, 2023. The increase in net loss is mainly due to the increased operating expenses.

Previous wording

Results of Operation for the six months ended September 30, 2024 and 2023

Current wording

Results of Operation for the nine months ended December 31, 2024 and 2023

Previous wording

During the six months ended September 30, 2024 and 2023, the Company generated revenue in the amount of $375,243 and $1,200, respectively. During the six months ended September 30, 2024 and 2023, the Company incurred operating expenses of $772,405 and $55,305, respectively. The increase in revenues and costs are related to the sales of health and beauty products which commenced since October 1, 2023. The Company also generated revenues in the amounts of $251,507 for its online platform technical operation support and maintenance services during the six months ended September 30, 2024.

Current wording

During the nine months ended December 31, 2024, and 2023, the Company generated revenues of $529,714 and $7,499, respectively, and incurred operating expenses of $1,120,531 and $157,938, respectively. The increase in revenue and costs was primarily due to revenues generated from its online platform technical operation support and maintenance services, which was $529,714 for the nine months ended December 31, 2024, compared to $nil in same period in 2023. In contrast, revenue for the nine months ended December 31, 2023, was solely from health and beauty product sales and online advertising in the amount of $7,499.

Previous wording

For the six months ended September 30, 2024, our net loss was $411,654 comparing to a net loss of $54,105 for the six months ended September 30, 2023. The increase in net loss is mainly due to the increased operating expenses.

Current wording

For the nine months ended December 31, 2024, our net loss was $540,808 comparing to a net loss of $151,196 for the nine months ended December 31, 2023. The increase in net loss is mainly due to the increased operating expenses.

Previous wording

As of September 30, 2024, we had an accumulated deficit of $1,100,957; cash of $37,403; and a working capital deficit of $986,427, compared to accumulated deficit of $689,303; cash of $166,552 and a working capital deficit of $647,227 as of March 31, 2024.

Current wording

As of December 31, 2024, we had an accumulated deficit of $1,230,111; cash of $202,487; and working capital of $293,921, compared to accumulated deficit of $689,303; cash of $166,552 and a working capital deficit of $647,227 as of March 31, 2024.

Previous wording

The increase in the working capital deficit was primarily driven by a rise in other receivables and current assets, an increase in account receivable, increased advances to suppliers, a increase in accounts payable and accrued expenses, and an increase in other payables, which affected available cash.

Current wording

The increase in the working capital was primarily driven by the conversion of certain debts into long-term notes payable, along with increases in other receivables and current assets. Additionally, there was a rise in accounts receivable, advances to suppliers, accounts payable and accrued expenses, and other payables, which impacted available cash.

Previous wording

The Company’s net loss was partially offset by non-cash expenses, including $71,921 in depreciation and $150,385 in amortization related to right-of-use (ROU) assets, mainly associated with leased office spaces and leasehold improvements.

Current wording

The Company’s net loss was partially offset by non-cash expenses, including $108,180 in depreciation and $256,749 in amortization related to right-of-use (ROU) assets, mainly associated with leased office and retail spaces and leasehold improvements.

Previous wording

As of September 30, 2024, we held approximately $37,403 in cash and cash equivalents and did not have any outstanding bank loans. Our liabilities are primarily funded by shareholder loans, which do not require immediate repayment. Operations are continuing as usual, and management is committed to implementing expense control measures in the near term to support liquidity.

Current wording

As of December 31, 2024, we held approximately $202,487 in cash and cash equivalents. Our liabilities are primarily funded by shareholder loans and unrelated parties’ loans, which do not require immediate repayment. Operations are continuing as usual, and management is committed to implementing expense control measures in the near term to support liquidity.